Tofacitinib Retreatment Effective for Ulcerative Colitis

Tofacitinib Retreatment Effective for Ulcerative Colitis

Uncategorized

Medical response can also be recaptured in patients who comprise had to interrupt treatment with tofacitinib, a JAK inhibitor, for up to 2 months, an evaluation of info from the OCTAVE extension trial reveals. Medscape Medical News
Learn More

Leave a Reply

Your email address will not be published. Required fields are marked *